(Q40140803)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460700%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells (English)

1 reference

29 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460700%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

6

Lust JA

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460700%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Kline MP

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460700%20AND%20SRC:MED&resulttype=core&format=json

1

1 reference

29 December 2019

Timm MM

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460700%20AND%20SRC:MED&resulttype=core&format=json

3

1 reference

29 December 2019

Kimlinger TK

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460700%20AND%20SRC:MED&resulttype=core&format=json

4

1 reference

29 December 2019

Haug JL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460700%20AND%20SRC:MED&resulttype=core&format=json

5

1 reference

29 December 2019

Greipp PR

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460700%20AND%20SRC:MED&resulttype=core&format=json

7

1 reference

29 December 2019

Kumar S

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460700%20AND%20SRC:MED&resulttype=core&format=json

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460700%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

26 April 2007

1 reference

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460700%20AND%20SRC:MED&resulttype=core&format=json

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460700%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460700%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

1549-1560

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460700%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

7

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404719

29 December 2019

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Response to interferon therapy in patients with multiple myeloma correlates with expression of the Bcl-2 oncoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Molecular sequelae of proteasome inhibition in human multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Targeted overexpression of Bcl-XL in B-lymphoid cells results in lymphoproliferative disease and plasma cell malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Killing cancer cells by flipping the Bcl-2/Bax switch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Antimyeloma activity of two novel N-substituted and tetraflourinated thalidomide analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Apoptosis in multiple myeloma: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Overcoming Drug Resistance in Multiple Myeloma: The Emergence of Therapeutic Approaches to Induce Apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Effect of the combination of docetaxel, zoledronic acid, and a COX-2 inhibitor on the growth of human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

The proteasome inhibitor bortezomib promotes mitochondrial injury and apoptosis induced by the small molecule Bcl-2 inhibitor HA14-1 in multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Discovering high-affinity ligands for proteins: SAR by NMR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Myeloid cell factor-1 is a critical survival factor for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

A cellular model for myeloma cell growth and maturation based on an intraclonal CD45 hierarchy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Mcl-1 regulation and its role in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

Multiple myeloma: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

7 January 2021

Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

7 January 2021

Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

7 January 2021

Decreased response to paclitaxel versus docetaxel in HER-2/neu transfected human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

7 January 2021

CD45 expression by bone marrow plasma cells in multiple myeloma: clinical and biological correlations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

7 January 2021

Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease in the Mcl-1/Bim complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404719

7 January 2021

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460700%20AND%20SRC:MED&resulttype=core&format=json

Identifiers

DOI

10.1038/SJ.LEU.2404719

1 reference